Clinical Trial Market Research Reports & Industry Analysis

Angelman Syndrome (AS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AS therapeutics. There will be more than 313,981 diagnosed prevalent cases of AS in 2023 in ...

Global Cell and Gene Therapy Clinical Trial Market 2023-2029 Cell therapy aims to treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body. With cell therapy, cells are cultivated or modified outside the body before being injected into the p ...

Is the Metaverse Virtually a Reality for Life Science R&D? This IDC Perspective reviews the significant potential of the metaverse and how it could transform the life science industry. It covers key use cases, analyzes the vendor landscape, reviews implementation challenges, and provides guidance to ...

Chemotherapy Drugs- Market Insights, Competitive Landscape, and Market Forecast - 2027 Chemotherapy Drugs Market By Drug Class (Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer ...

Global Clinical Trial Imaging Market Report, History and Forecast 2018-2029 Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Clinical Trial Imaging estimated was at US$ 1,373.38 million in the year 2022, is projected to reach a revised size of US$ 2,208.53 million ...

Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Influenza Prophylactics therapeutics. Across the 16 major markets, there were ove ...

Heart Failure (HF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HF therapeutics. There are more than 45.9 million diagnosed prevalent cases of heart failure in ...

Essential Tremor (ET) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ET therapeutics. There will be more than 6,000,000 diagnosed prevalent cases of ET in 2023 i ...

Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spo ...

Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ITP therapeutics. There will be more than 1.6 million diagnosed prevalent cases of I ...

Thalassemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Thalassemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Typ ...

Postherpetic Neuralgia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Postherpetic Neuralgia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Point ...

Cognitive Impairment Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Cognitive Impairment Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, S ...

Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Sta ...

Cellulitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Cellulitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type ...

Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spons ...

Fragile X Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Fragile X Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Statu ...

Malaria Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Malaria Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and To ...

Gastric Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Gastric Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spons ...

Non-Small Cell Lung Cancer (NSCLC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecas ...

Pompe Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies Pompe Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development ...

Pyelonephritis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies Pyelonephritis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under developme ...

Opioid Use Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Opioid Use Disorder therapeutics. There are 2.4 million diagnosed prevalent cases of opioid us ...

Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides a ...

The 2023 Global: Clinical Trial Equipment & Ancillary Solutions - Innovative Markets Forecast (2029) report analyzies the market size, projected growth/decline and regional data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our p ...